Voloridge Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,140
| Closed | -$579K | – | 1484 |
|
|
2022
Q1 | $579K | Sell |
8,140
-37,343
| -82% | -$2.66M | ﹤0.01% | 1204 |
|
|
2021
Q4 | $3.4M | Buy |
45,483
+33,319
| +274% | +$2.49M | 0.02% | 867 |
|
|
2021
Q3 | $691K | Buy |
+12,164
| New | +$691K | ﹤0.01% | 1382 |
|
|
2021
Q1 | – | Sell |
-50,052
| Closed | -$2.11M | – | 1465 |
|
|
2020
Q4 | $2.11M | Buy |
50,052
+799
| +2% | +$33.6K | 0.02% | 719 |
|
|
2020
Q3 | $2.26M | Buy |
49,253
+19,330
| +65% | +$885K | 0.02% | 679 |
|
|
2020
Q2 | $1.5M | Sell |
29,923
-24,560
| -45% | -$1.23M | 0.02% | 712 |
|
|
2020
Q1 | $2.8M | Buy |
54,483
+17,707
| +48% | +$911K | 0.08% | 270 |
|
|
2019
Q4 | $2.27M | Buy |
36,776
+24,808
| +207% | +$1.53M | 0.04% | 459 |
|
|
2019
Q3 | $719K | Buy |
+11,968
| New | +$719K | 0.01% | 716 |
|
|
2019
Q2 | – | Sell |
-11,288
| Closed | -$1.08M | – | 836 |
|
|
2019
Q1 | $1.08M | Sell |
11,288
-4,383
| -28% | -$419K | 0.03% | 447 |
|
|
2018
Q4 | $1.11M | Buy |
+15,671
| New | +$1.11M | 0.05% | 260 |
|